CRYOPDP, a global leader in temperature-controlled logistics for the life sciences industry, is proud to announce that its acquisition by DHL Supply Chain has been formally approved. With this milestone, CRYOPDP is now officially integrated into DHL’s Pharma Specialised Network (PSN), reinforcing its role as a key player in global healthcare logistics.

The strategic integration enhances CRYOPDP’s service capabilities across the pharmaceutical, biopharmaceutical, and advanced therapy sectors. Backed by the extensive global footprint and expertise of DHL Health Logistics, CRYOPDP is poised to deliver even more flexible, reliable, and precise temperature-controlled logistics solutions—designed to support clinical trials, pharmaceutical distribution, and critical life sciences supply chains worldwide.

To reflect this evolution, CRYOPDP is also unveiling a new brand identity, underscoring its purpose-driven mission: Connecting what matters. The updated brand communicates the company’s core values of precision, flexibility, purpose, and trust, and affirms CRYOPDP’s position as more than a logistics provider—it is a vital link between science, systems, and people.